MS
ABEO icon

Maven Securities’s Abeona Therapeutics ABEO Stock Holding History

Maven Securities’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,830
Closed -$328K – 1009
2021
Q1 		$328K Buy
+6,830
New +$376K 0.01% 782
2020
Q1 		– Sell
-3,000
Closed -$255K – 295
2019
Q4 		$255K Buy
+3,000
New +$212K 0.02% 321

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Maven Securities's ABEO Position: Q2 2021 in Review

Maven Securities sold out of Abeona Therapeutics (ABEO) in Q2 2021, closing a stake of 6,830 shares — an estimated $328K sold.

Maven Securities first reported a position in ABEO in Q4 2019 and held it in 2 quarters. The position peaked at $328K in Q1 2021. 70 funds tracked by Wall St. Rank hold ABEO as of Q2 2021.

  • Maven Securities reported no remaining Abeona Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Maven Securities sold 6,830 Abeona Therapeutics shares in Q2 2021, an estimated $328K.
  • Maven Securities first reported a position in Abeona Therapeutics in Q4 2019 and held it in 2 quarters.
  • Maven Securities's Abeona Therapeutics position peaked at $328K in Q1 2021.
  • 70 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2021.

Based on Maven Securities's 13F filing for Q2 2021, filed 16 Aug 2021.